Insulet Corporation

NASDAQ
PODD
Stock
Yield per half year: +21.09%
Dividend yield: 0%
Sector: Healthcare

318 $

-8.97 $ ( 2.74%)
229.13 $
352.82 $

Min/max per year

Share chart Insulet Corporation

Main settings

Currency
usd
Dividend income of JSC
0
IPO Time
2007-05-15
ISIN
US45784P1012
Industry
Health Care Equipment & Supplies
Report Currency
usd
Sector
Health Care
Website

Grade

Underestimation
Title Value Grade
P/S 9.39 1
P/BV 16.06 1
P/E 46.52 3
Efficiency
Title Value Grade
ROA 14.74 4
ROE 43.03 10
ROIC 5.25 2
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0 0
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA 3.29 4
Debt/Ratio 0.4509 10
Debt/Equity 1.55 7
Growth impulse
Title Value Grade
Revenue, bln, % 129.16 10
Ebitda, % 285.18 10
EPS, % 5561.12 10

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 326.97 $ 0 $ 0 $ -2.74 % 0 % 0 %
Week 330.84 $ 0 $ 0 $ -3.88 % 0 % 0 %
Month 337.6 $ 318 $ 352.82 $ -5.81 % 0 % 0 %
Three month 313.08 $ 277.3 $ 352.82 $ +1.57 % 0 % 0 %
Half a year 262.61 $ 238.57 $ 352.82 $ +21.09 % 0 % 0 %
Year 205.15 $ 229.13 $ 352.82 $ +55.01 % 0 % 0 %
3 years 297.56 $ 130.7 $ 352.82 $ +6.87 % 0 % 0 %
5 years 74.88 $ 130.7 $ 352.82 $ +324.68 % 0 % 0 %
10 years 14.95 $ 24.68 $ 352.82 $ +2 027.09 % 0 % 0 %
Year to date 266.57 $ 237.06 $ 352.82 $ +19.29 % 0 % 0 %

Insider trading

Main owners

Contained in ETF

ETF
Share, %
Profitability for 1 year, %
Commission, %
Global X Telemedicine & Digital Health ETF Registered 5.20363 -4.06 0.68
Harbor Disruptive Innovation ETF 0.5779 0.7391 0.75
Fidelity Growth Opportunities ETF 0.38428 -18.43 0.38
iShares Morningstar Mid-Cap Growth ETF 0.30698 365.62 0.06
iShares Morningstar Mid-Cap ETF 0.15338 223.35 0.04
iShares Morningstar Large-Cap Growth ETF 0.06781 205.79 0.04
Columbia U.S. ESG Equity Income ETF 0.0575 -0.4785 0.35
iShares Factors US Growth Style ETF 0.04785 -14.56 0.25
iShares Morningstar Large-Cap ETF 0.03237 173.76 0.03
0.76103.530.29

Similar companies



Company management

Head Job title Payment Year of birth
Ms. Lauren Budden Group VP, Chief Accounting Officer & Controller N/A 1975 (50 years)
Ms. Deborah R. Gordon CPA Vice President of Investor Relations N/A 1971 (54 years)
Mr. John Wodick Kapples Senior VP & General Counsel 783.36k 1960 (65 years)
Dr. James R. Hollingshead Ph.D. President, CEO & Director 2.18M 1963 (62 years)
Mr. Prem Singh Senior Vice President of Global Operations N/A 1977 (48 years)
Ms. Laetitia Cousin Senior VP of Regulatory Affairs, Quality Assurance & Compliance N/A 1976 (49 years)
Mr. Eric Benjamin Executive VP, Chief Product & Customer Experience Officer 947.57k 1983 (42 years)
Mr. Mark Field Senior VP & CTO N/A 1971 (54 years)
Angela Geryak Wiczek Senior Director of Corporate Communications N/A
Ms. Ana Maria Chadwick Executive VP, CFO & Treasurer 1972 (53 years)

About company

Address: United States, Acton, 100 Nagog Park - Open in google maps, Open in yandex maps
Website: http://www.insulet.com

About Insulet Corporation

Корпорация Insulet разрабатывает, производит и продает системы доставки инсулина для людей с инсулинозависимым диабетом. Он предлагает систему Omnipod, самоклеящееся одноразовое бескамерное устройство Omnipod, которое носится на теле до трех дней одновременно, а также беспроводной компаньон, портативный персональный менеджер диабета. Компания продает свою продукцию в основном через независимых дистрибьюторов и аптечные каналы, а также непосредственно в Соединенных Штатах, Канаде, Европе и на Ближнем Востоке. Корпорация Insulet была основана в 2000 году со штаб-квартирой в Актоне, штат Массачусетс.